Commentary |

Should Sisyphus Have Taken Melatonin?

William M. Glazer, MD; Scott W. Woods, MD; Don Goff, MD
Arch Gen Psychiatry. 2001;58(11):1054-1055. doi:10.1001/archpsyc.58.11.1054.
Text Size: A A A
Published online


IS MELATONIN a new inroad into the treatment and understanding of the pathophysiologic characteristics of tardive dyskinesia (TD), or is it just another boulder in the Sisyphean history of treatments for iatrogenic conditions? In this issue of the ARCHIVES, Shamir et al1 report the effectiveness of a 6-week trial of melatonin, 10 mg/d, relative to placebo in 22 patients. The authors postulate, among many possible mechanisms,2 that melatonin asserts a modulatory effect on dopamine release or a neuroprotective, antioxidative action on brain dopaminergic functioning. What is the relevance of this finding to research strategies and treatment approaches in patients? Certainly TD has been a driving force behind the effort to develop better antipsychotic agents. The estimated 68% risk of TD after 20 to 25 years of exposure to the older "typical" antipsychotic drugs is a public health problem.3 Unquestionably, we need ways to treat and prevent this iatrogenic condition.



Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview





Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment


Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Topics
PubMed Articles